Predictors of Therapy Failure in Newly Diagnosed Pulmonary Tuberculosis Cases in Beira, Mozambique

Overview

Journal BMC Res Notes

Publisher Biomed Central

Specialties Biology
General Medicine

Date 2018 Feb 7

PMID 29402317

Citations 28

Authors

Damiano Pizzol

Nicola Veronese

Claudia Marotta

Francesco Di Gennaro

Jorge Moiane

Kajal Chhaganlal

Laura Monno

Giovanni Putoto

Walter Mazzucco

Annalisa Saracino

Affiliations

Soon will be listed here.

Abstract

Objective: Tuberculosis (TB) remains a major global health issue, ranking in the top ten causes of death worldwide. A deep understanding of factors influencing poor treatment outcomes may allow the development of additional treatment strategies, focused on the most vulnerable groups. Aims of the study were: (i) to evaluate the treatment outcome among TB subjects followed in an outpatient setting and (ii) to analyze factors associated with treatment failure in newly diagnosed patients with pulmonary TB in Beira, the second largest city of Mozambique.

Results: A total of 301 TB adult patients (32.6% females) were enrolled. Among them, 62 (20.6%) experienced a treatment failure over a 6 months follow-up. On multivariate model, being males (O.R. = 1.73; 95% CI 1.28-2.15), absence of education (O.R. = 1.85; 95% CI 1.02-2.95), monthly income under 50 dollars (O.R. = 1.74; 95% CI 1.24-2.21) and being employed (O.R. = 1.57; 95% CI 1.21-1.70), low body mass index values (O.R. = 1.42; 95% CI 1.18-1.72) and HIV status (O.R. = 1.42; 95% CI 1.10-1.78) increased the likelihood of therapy failure over 6 months of follow-up. In this study, patients who need more medical attention were young males, malnourished, with low income and low educational degree and HIV positive. These subjects were more likely to fail therapy.

Citing Articles

Determinants of unsuccessful tuberculosis treatment outcome in Southwest Ethiopia regional state public hospitals, 2022: a multi-center case control study.

Berihe Hiluf S, Abera A, Bahiru M, Kassie B Front Public Health. 2024; 12:1406211.

PMID: 39502821 PMC: 11534863. DOI: 10.3389/fpubh.2024.1406211.

Survival Probability in Multidrug Resistant Pulmonary Tuberculosis Patients in a South Indian Region.

Smitha T, Sunitha P, Prabhakar O, Vasudeva Murthy S Hosp Pharm. 2024; 59(4):427-435.

PMID: 38919760 PMC: 11195841. DOI: 10.1177/00185787231224065.

Dietary patterns and micronutrients in respiratory infections including COVID-19: a narrative review.

Salehi Z, Askari M, Jafari A, Ghosn B, Surkan P, Hosseinzadeh-Attar M BMC Public Health. 2024; 24(1):1661.

PMID: 38907196 PMC: 11193220. DOI: 10.1186/s12889-024-18760-y.

Successful Management, in a Low-Resource Setting, of Disseminated Tuberculosis in a 3-Year Old Boy: A Case Report.

Chilundo J, Muhelo A, Ahivaldino Z, Zucula H, Macuacua S, Mussagi A Pathogens. 2023; 12(9).

PMID: 37764971 PMC: 10537502. DOI: 10.3390/pathogens12091163.

High risk of unsuccessful treatment outcome in migrant population with tuberculosis: Data from three Italian hospitals.

Di Gennaro F, Cotugno S, Fasano M, Ricciardi A, Ronga L, Lattanzio R Front Public Health. 2023; 10:1024474.

PMID: 36703820 PMC: 9871451. DOI: 10.3389/fpubh.2022.1024474.

References

Garcia-Basteiro A, Respeito D, Augusto O, Lopez-Varela E, Sacoor C, Sequera V . Poor tuberculosis treatment outcomes in Southern Mozambique (2011-2012). BMC Infect Dis. 2016; 16:214. PMC: 4874028. DOI: 10.1186/s12879-016-1534-y. View

Di Gennaro F, Pizzol D, Cebola B, Stubbs B, Monno L, Saracino A . Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review. Tuberculosis (Edinb). 2017; 103:44-51. DOI: 10.1016/j.tube.2017.01.002. View

Bruchfeld J, Correia-Neves M, Kallenius G . Tuberculosis and HIV Coinfection. Cold Spring Harb Perspect Med. 2015; 5(7):a017871. PMC: 4484961. DOI: 10.1101/cshperspect.a017871. View

. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 385(9963):117-71. PMC: 4340604. DOI: 10.1016/S0140-6736(14)61682-2. View

Waitt C, Squire S . A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis. 2011; 15(7):871-85. DOI: 10.5588/ijtld.10.0352. View

Adenager G, Alemseged F, Asefa H, Gebremedhin A . Factors Associated with Treatment Delay among Pulmonary Tuberculosis Patients in Public and Private Health Facilities in Addis Ababa, Ethiopia. Tuberc Res Treat. 2017; 2017:5120841. PMC: 5350388. DOI: 10.1155/2017/5120841. View

Wang X, Yin S, Du J, Du M, Wang P, Wu J . Risk factors for the treatment outcome of retreated pulmonary tuberculosis patients in China: an optimized prediction model. Epidemiol Infect. 2017; 145(9):1805-1814. PMC: 9203337. DOI: 10.1017/S0950268817000656. View

Pizzol D, Di Gennaro F, Chhaganlal K, Fabrizio C, Monno L, Putoto G . Prevalence of diabetes mellitus in newly diagnosed pulmonary tuberculosis in Beira, Mozambique. Afr Health Sci. 2017; 17(3):773-779. PMC: 5656213. DOI: 10.4314/ahs.v17i3.20. View

Nglazi M, Bekker L, Wood R, Kaplan R . The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study. BMC Infect Dis. 2015; 15:536. PMC: 4653912. DOI: 10.1186/s12879-015-1275-3. View

10.

Gandhi N, Moll A, Sturm A, Pawinski R, Govender T, Lalloo U . Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006; 368(9547):1575-80. DOI: 10.1016/S0140-6736(06)69573-1. View

11.

Koethe J, von Reyn C . Protein-calorie malnutrition, macronutrient supplements, and tuberculosis. Int J Tuberc Lung Dis. 2016; 20(7):857-63. DOI: 10.5588/ijtld.15.0936. View

12.

Sinshaw Y, Alemu S, Fekadu A, Gizachew M . Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study. BMC Infect Dis. 2017; 17(1):132. PMC: 5299781. DOI: 10.1186/s12879-017-2238-7. View

13.

Costa-Veiga A, Briz T, Nunes C . Unsuccessful treatment in pulmonary tuberculosis: factors and a consequent predictive model. Eur J Public Health. 2017; 28(2):352-358. DOI: 10.1093/eurpub/ckx136. View

14.

. (2) Classification and diagnosis of diabetes. Diabetes Care. 2014; 38 Suppl:S8-S16. DOI: 10.2337/dc15-S005. View

15.

Garcia-Basteiro A, Lopez-Varela E, Manhica I, Macete E, Alonso P . Mozambique faces challenges in the fight against tuberculosis. Lancet. 2014; 383(9913):215-6. DOI: 10.1016/S0140-6736(14)60069-6. View

16.

Muture B, Keraka M, Kimuu P, Kabiru E, Ombeka V, Oguya F . Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health. 2011; 11:696. PMC: 3224095. DOI: 10.1186/1471-2458-11-696. View

17.

Cai J, Wang X, Ma A, Wang Q, Han X, Li Y . Factors associated with patient and provider delays for tuberculosis diagnosis and treatment in Asia: a systematic review and meta-analysis. PLoS One. 2015; 10(3):e0120088. PMC: 4373856. DOI: 10.1371/journal.pone.0120088. View